Atrial tachyarrhythmias and cardiac resynchronisation therapy: Clinical and therapeutic implications

Heart

Volumn 96, Issue 15, 2010, Pages 1174-1178

  Lavalle, Carlo ^a   Ricci, Renato P ^a   Santini, Massimo ^a  

^a SAN FILIPPO NERI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIOVENTRICULAR JUNCTION ARRHYTHMIA; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL TRIAL; DEFIBRILLATOR; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; IMPLANTATION; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; REVIEW; SINUS RHYTHM; SURVIVAL RATE; THROMBOEMBOLISM;

ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; HEART ATRIA; HEART FAILURE; HUMANS; RECURRENCE;

EID: 77954728140     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2009.184523     Document Type: Review

References (32)

1. Braunwald E. Shattuck lecture-cardiovascular medicine at the turn of the millenium: triumphs, concerns and opportunities. N Engl J Med 1997;337:1360. (Pubitemid 27467771)
2. Leclercq C, Victor F, Alonso C, et al. Comparative effects of permanent biventricular pacing for refractory heart failure in patients with stable sinus rhythm or chronic atrial fibrillation. Am J Cardiol 2000;85:1154-6. (Pubitemid 30214269)
3. Leon AR, Greenberg JM, Kanuru N, et al. Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation: effects of upgrading to biventricular pacing after chronic right ventricular pacing. J Am Coll Cardiol 2002;39:1258-63. (Pubitemid 34297863)
4. Leclercq C, Walker S, Linde C, et al. Comparative effects of permanent biventricular and right ventricular pacing in heart failure patients with chronic atrial fibrillation. Eur Heart J 2002;23:1780-878. (Pubitemid 35334271)
5. Linde C, Leclercq C, Rex S, et al. Long-term benefits of biventicular pacing in congestive heart failure: results from the Multisite Stimulation in Cardiomyopathy (MUSTIC) study. J Am Coll Cardio 2002;40:111-18.
6. Molhoek SG, Bax JJ, Bleeker GB, et al. Comparison of response to cardiac resynchronization therapy in patients with sinus rhythm versus chronic atrial fibrillation. Am J Cardiol 2004;94:1506-9.
7. Upadhyay GA, Choudhry NK, Auricchio A, et al. Cardiac resynchronization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies. J Am Coll Cardiol 2008;52:1239-46.
8. Ferreira AM, Adraga P, Cavaco D, et al. Benefits of cardiac resynchronization therapy in atrial fibrillation patients vs patients in sinus rhythm: the role of atrioventricular junction ablation. Europace 2008;10:809-15. (Pubitemid 351882072)
9. Gasparini M, Auricchio A, Metra M, et al. Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation. Eur Heart J 2008;29:1644-52. (Pubitemid 351957539)
10. Gasparini M, Lunati M, Padeletti L, et al. InSync/InSync ICD Italian Registries Invstigators. Persistence of intrinsic conduction in patients with atrial fibrillation treated with cardiac resynchronization therapy: the InSync Italian Registry. Proceedings from the 15 World Congress in Cardiac Electrophysiology and Cardiac Techniques Cardiostim, 2006.
11. Vardas PE, Auricchio A, Blanc JJ, et al. Guidelines for cardiac pacing and cardiac resynchronization therapy: the Task Force for cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Eur Heart J 2007;28:2256-95.
12. Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 guidelines for device-base therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2008;117:-e50-408.
13. Hoppe UC, Casares JM, Eiskjær H, et al. Effect of cardiac resynchronization on the incidence of atrial fibrillation in patients with severe heart failure. Circulation 2006;114:18-25.
14. Hugl B, Bruns HJ, Unterberg-Buchwald C, et al. Atrial fibrillation burden during the post-implant period after CRT using device-based diagnostics. J Cardiovasc Electrophysiol 2006;17:813-17.
15. Lellouche N, De Diego C, Vaseghi M, et al. Cardiac resynchronization therapy is associated with shorter duration of atrial fibrillation. Pacing Clin Electrophysiol 2007;30:1363-8.
16. Fung JWH, Yip GWK, Zhang Q, et al. Improvement of left atrial function is associated with lower incidence of atrial fibrillation and mortality after cardiac resynchronization therapy. Heart Rhythm 2008;5:780-6.
17. Kies P, Leclercq C, Bleeker GB, et al. Cardiac resynchronization therapy in chronic atrial fibrillation: impact on left atrial size and reversal to sinus rhythm. Heart 2006;92:490-4.
18. Deedwania PC, Singh BN, Ellenbogen K, et al. Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation. observations from the veterans affair congestive heart failure survival trail of antiarrhythmic therapy (CHF-STAT). Circulation 1998;98:2574-9.
19. The AFFIRM First Antiarrhythmic Drug Substudy Investigators. Maintenance of sinus rhythm in patients with atrial fibrillation: an AFFIRM substudy of the first antiarrhythmic drug. J Am Coll Cardiol 2003;42:20-9.
20. The AFFIRM Investigators. Relationship between sinus rhythm, treatment and survival in the atrial fibrillation follow-up investigation of rhythm management (AFFIRM) study. Circulation 2004;109:1509-13.
21. Chen MS, Marrouche NF, Khaykin Y, et al. Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function. J Am Coll Cardiol 2004;43:1004-9.
22. Hsu LF, Jais P, Sanders P, et al. Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med 2004;351:2373-83.
23. Khan MN, Jais P, Cummings J, et al. for the PABA-CHF Investigators. Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. N Engl J Med 2008;359:1778-85.
24. Gentlesk PJ, Sauer WH, Gerstenfeld EP, et al. Reversal of left ventricular dysfunction following ablation of atrial fibrillation. J Cardiovasc Electrophysiol 2007;18:9-14.
25. Marrouche NF, Brachmann J. CASTLE-AF Steering Committee. Catheter ablation versus standard conventional treatment in patients with left ventricular dysfunction and atrial fibrillation (CASTLE-AF) study design. Pacing Clin Electrophysiol 2009;32:987-94.
26. Puglisi A, Gasparini M, Lunati M, et al. Persistent atrial fibrillation worsens heart rate variability, activity and heart rate, as shown by a continuous monitoring by implantable biventricular pacemakers in heart failure patients. J Cardiovasc Electrophysiol 2008;19:693-701.
27. Capucci A, Santini M, Padeletti L, et al. Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering with bradycardia and atrial fibrillation implanted with antitachycardia pacemakers. J Am Coll Cardiol 2005;46:1913-20.
28. Ricci RP, Morichelli L, Santini M. Remote control of implanted devices through home monitoring™ technology improves detection and clinical management of atrial fibrillation. Europace 2009;11:54-61.
29. Ricci RP, Morichelli L, Gargaro A, et al. Home monitoring in patients with implantable cardiac devices: is there a potential risk reduction of stroke risk? results from a computer model tested through monte carlo simulations. J Cardiovasc Electrophysiol Published Online First: 13 July 2009. PubMed PMID:19602024.
30. Ricci R, Pignalberi C, Disertori M, et al. Antitachycardia pacing therapy to treat spontaneous atrial tachyarrhythmias: the 7250 Dual Defibrillator Italian Registry. Eur Heart J Suppl 2001;3(Suppl P):P25-32.
31. Ricci R, Pignalberi C, Disertori M, et al. Efficacy of a dual chamber defibrillator with atrial antitachycardia functions in treating spontaneous atrial tachyarrhythmias in patients with life-threatening ventricular tachyarrhythmias. Eur Heart J 2002;23:1471-9.
32. Santini M, Ricci R, Pignalberi C, et al. Is dual defibrillator better than conventional DDD pacing in brady-tachy syndrome? Results of the ICARUS Trial (Internal Cardioversion Antitachypacing and Prevention: Resource Utilization Study). J Interv Card Electrophysiol 2005;14:159-68.